| Nanocapsules for drug delivery: an updated review of the last decade N Erdoğar, S Akkın, E Bilensoy Recent Patents on Drug Delivery & Formulation 12 (4), 252-266, 2018 | 91 | 2018 |
| A review on cancer immunotherapy and applications of nanotechnology to chemoimmunotherapy of different cancers S Akkın, G Varan, E Bilensoy Molecules 26 (11), 3382, 2021 | 73 | 2021 |
| Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver G Varan, S Akkın, N Demirtürk, JM Benito, E Bilensoy Journal of drug targeting 29 (4), 439-453, 2021 | 24 | 2021 |
| Development of oral aprepitant-loaded chitosan–polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation N Erdoğar, S Akkın, TT Nielsen, E Özçelebi, B Erdoğdu, E Nemutlu, ... Journal of pharmaceutical investigation 51, 297-310, 2021 | 17 | 2021 |
| A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU S Akkın, G Varan, D Aksüt, M Malanga, A Ercan, M Şen, E Bilensoy International Journal of Pharmaceutics 623, 121940, 2022 | 13 | 2022 |
| Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer N Erdoğar, S Akkın, G Varan, E Bilensoy Pharmaceutical Development and Technology 26 (7), 797-806, 2021 | 6 | 2021 |
| Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer … S Akkın, G Varan, A Isık, S Göksen, E Karakoç, M Malanga, G Esendaglı, ... | 1 | 2023 |
| Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer S Akkın, G Varan, A Işık, S Gökşen, E Karakoç, M Malanga, G Esendağlı, ... Pharmaceutics 15 (2), 314, 2023 | | 2023 |
| İmmünokemoterapötik nanoplekslerin kolon kanseri tedavisinde etkinlik ve güvenliğinin in vitro-in vivo değerlendirilmesi S Akkın Sağlık Bilimleri Enstitüsü, 0 | | |
| Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer N ERDOĞDU, S Akkın, G VARAN, E BİLENSOY | | |
